The U.S. Food and Drug Administration has approved the ORBERA™ Intragastric Balloon to assist adult patients suffering from obesity in losing and maintaining weight loss. Obesity affects more than 78.6 million U.S. adults and is one of the leading causes … [Read more...] about FDA Approves Non-Surgical Solution ORBERA™ To Assist Patients With Weight Loss